BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15909458)

  • 1. Does the flap of a butterfly's wings in Brazil set off a tornado in Texas?--The JC Virus Story in multiple sclerosis.
    Achiron A; Miron S; Shoenfeld Y
    Isr Med Assoc J; 2005 May; 7(5):283-5. PubMed ID: 15909458
    [No Abstract]   [Full Text] [Related]  

  • 2. JC viral loads in patients with Crohn's disease treated with immunosuppression: can we screen for elevated risk of progressive multifocal leukoencephalopathy?
    Verbeeck J; Van Assche G; Ryding J; Wollants E; Rans K; Vermeire S; Pourkarim MR; Noman M; Dillner J; Van Ranst M; Rutgeerts P
    Gut; 2008 Oct; 57(10):1393-7. PubMed ID: 18436577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients at risk.
    Drazen JM
    N Engl J Med; 2005 Jul; 353(4):417. PubMed ID: 15947081
    [No Abstract]   [Full Text] [Related]  

  • 4. Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences.
    Berger JR; Koralnik IJ
    N Engl J Med; 2005 Jul; 353(4):414-6. PubMed ID: 15947082
    [No Abstract]   [Full Text] [Related]  

  • 5. Reactivation of JC virus and development of PML in patients with multiple sclerosis.
    Khalili K; White MK; Lublin F; Ferrante P; Berger JR
    Neurology; 2007 Mar; 68(13):985-90. PubMed ID: 17389301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natalizumab for relapsing multiple sclerosis.
    Meyer MA
    N Engl J Med; 2006 Jun; 354(22):2387-9; author reply 2387-9. PubMed ID: 16742009
    [No Abstract]   [Full Text] [Related]  

  • 7. Reemergence of PML in natalizumab-treated patients--new cases, same concerns.
    Major EO
    N Engl J Med; 2009 Sep; 361(11):1041-3. PubMed ID: 19741226
    [No Abstract]   [Full Text] [Related]  

  • 8. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis.
    Kleinschmidt-DeMasters BK; Tyler KL
    N Engl J Med; 2005 Jul; 353(4):369-74. PubMed ID: 15947079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natalizumab and PML: a risky business?
    Clifford DB
    Gut; 2008 Oct; 57(10):1347-9. PubMed ID: 18791114
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply to "'Thinking without thinking' about natalizumab and PML".
    Houff S; Berger JR
    J Neurol Sci; 2008 Jan; 264(1-2):198-9; author reply 199. PubMed ID: 17936798
    [No Abstract]   [Full Text] [Related]  

  • 11. Time is brain for infections too?
    Clifford DB
    Neurology; 2011 May; 76(20):1688-9. PubMed ID: 21576684
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of JC virus DNA in blood and urine from natalizumab-treated patients.
    Warnke C; Adams O; Hartung HP; Kieseier BC
    Ann Neurol; 2011 Jan; 69(1):215-6; author reply 216. PubMed ID: 21280097
    [No Abstract]   [Full Text] [Related]  

  • 13. Is detection of JC virus DNA in blood a valuable screening test for progressive multifocal leukoencephalopathy in Crohn's disease patients eligible for anti-alpha4 integrin therapy?
    Pineton de Chambrun G; Vernier-Massouille G; Viget N; Colombel JF; Yazdanpanah Y
    Gut; 2008 Nov; 57(11):1633-4; author reply 1634. PubMed ID: 18941016
    [No Abstract]   [Full Text] [Related]  

  • 14. Natalizumab for relapsing multiple sclerosis.
    Jeffery DR
    N Engl J Med; 2006 Jun; 354(22):2387-9; author reply 2387-9. PubMed ID: 16742008
    [No Abstract]   [Full Text] [Related]  

  • 15. Natalizumab (Tysabri) returns.
    Med Lett Drugs Ther; 2006 Sep; 48(1243):76. PubMed ID: 16977289
    [No Abstract]   [Full Text] [Related]  

  • 16. Asymptomatic reactivation of JC virus in patients treated with natalizumab.
    Warnke C; Adams O; Kieseier BC
    N Engl J Med; 2009 Dec; 361(25):2489; author reply 2489-90. PubMed ID: 20050216
    [No Abstract]   [Full Text] [Related]  

  • 17. Progressive multifocal leukoencephalopathy, natalizumab, and multiple sclerosis.
    Berger T; Deisenhammer F
    N Engl J Med; 2005 Oct; 353(16):1744-6; author reply 1744-6. PubMed ID: 16236749
    [No Abstract]   [Full Text] [Related]  

  • 18. Natalizumab: bound to rebound?
    Schiess N; Calabresi PA
    Neurology; 2009 Feb; 72(5):392-3. PubMed ID: 19188569
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of progressive multifocal leukoencephalopathy associated with natalizumab.
    Wenning W; Haghikia A; Laubenberger J; Clifford DB; Behrens PF; Chan A; Gold R
    N Engl J Med; 2009 Sep; 361(11):1075-80. PubMed ID: 19741228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natalizumab and progressive multifocal leukoencephalopathy.
    Adelman B; Sandrock A; Panzara MA
    N Engl J Med; 2005 Jul; 353(4):432-3. PubMed ID: 15947083
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.